Trial
Drugs
Congenital
Signs
CICU
100

This trial studied effects of clopidogrel in addition to aspirin in patients with ACS without STEMI.


Cure trial

100

Regadenoson is an agonist for these specific receptors


- A2A receptor

100

This condition is often associated with Noonan's syndrome, Large 'a' wave in JVP, RV heave, Ejection click and murmur, soft and late P2


- Pulmonary Stenosis

100

Contraction and dilation of pupil

-Landolfi's sign

100

Cardio selective B1 receptor blocker with rapid onset and a very short duration of action and no significant intrinsic sympa-thomimetic activity -

  Esmolol

200

This trial showed that addition of clopidogrel to aspirin, but not early use of metoprolol, improved overall outcomes in Acute Myocardial infarction.


Commit trial

200

This sodium-potassium adenosine triphosphatase inhibitor binds to amyloid fibrils and can lead to potential toxicity even at normal drug levels in amyloid heart patients


- Digoxin

200

Indication for Pulmonary stenosis balloon valvulotomy


-Symptomatic 

Mean gradient >30/Peak gradient > 50mmHg

 Asymptomatic 

Mean gradient >40/Peak gradient >60mm Hg, in association with less than moderate PR

200

Paradoxical rise in jugular venous pressure with inspiration 


-Kussmal’s sign

200

Combination of ECMO and impella for cardiogenic shock


-ECpella

300

Ezetimibe added to Statin therapy after ACS improved cardiovascular outcomes

– IMPROVE-IT trial

300

The mechanism of action of Eptifibatide 


- Glycoprotein IIb/Illa inhibitor

300

Most common cardiovascular condition during long term follow up of coarctation is

  -Hypertension

300

Drop in Diastolic blood pressure >15mm Hg after raising arm above head 


-Mayne's sign

300

Acc/AHA guideline recommends this LV systolic function for TEER in MR from LV dysfunction


-> 20%

400

In Primary PCI with multi vessel disease, index admission complete revascularization lowered rate of MACE at 12 months compared with treating only infarct related artery


CvLPRIT trial

400

Effect of amiodarone and Class Ic agents on defibrillation threshold

 -Increase defibrillation threshold

400

Indication for phlebotomy in Cyanotic congenital heart disease is -

  Hb > 20, Hct >65. Always replace fluid first

400

Pulsatile flushing of forehead 


- Lighthouse sign

400

This is when aortic pressure exceeds LV pressure during LVAD support and the aortic valve remains closed


LV – aortic pressure uncoupling

500

Programming of ICD therapies for tachyarrhythmias of 200 bpm or with a prolonged delay in therapy at 170 bpm or higher, as compared with conventional programming associated with reductions inappropriate therapy and all-cause mortality through long-term follow-up


MADIT RIT Trial

500

Treatment of choice for Belhassen's VT

-Verapamil

500

Atrial switch procedures for surgical treatment of transposition 


-Mustard and Senning

500

An auscultatory finding in aortic stenosis where the harsh, low‑frequency systolic murmur at the right upper sternal border becomes a high‑pitched, musical murmur at the apex, mimicking mitral regurgitation.

 

Gallavardin phenomenon

500

This the improved LV size and function in response to drug and device therapies for HFrEF


Reverse remodelling